SB-431542, a transforming growth factor β inhibitor, impairs Trypanosoma cruzi infection in cardiomyocytes and parasite cycle completion

Antimicrobial Agents and Chemotherapy

Volumn 51, Issue 8, 2007, Pages 2905-2910

  Waghabi, Mariana C ^a   Keramidas, Michelle ^b,c,d   Calvet, Claudia M ^a   Meuser, Marcos ^a   Soeiro, Maria De Nazaré C ^a   Mendonça Lima, Leila ^a   Araújo Jorge, Tania C ^a   Feige, Jean Jacques ^b,c,d   Bailly, Sabine ^b,c,d  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b INSERM   (France)

^c DIF   (France)

^d UNIV GRENOBLE ALPES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

4 [4 (1,3 BENZODIOXOL 5 YL) 5 (2 PYRIDINYL) 1H IMIDAZOL 2 YL]BENZAMIDE; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 1;

ANIMAL CELL; ARTICLE; CELL CYCLE; CHAGAS DISEASE; DRUG MECHANISM; EMBRYO; HEART MUSCLE CELL; MOUSE; NONHUMAN; PARASITE DEVELOPMENT; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TRYPANOSOMA CRUZI; TRYPOMASTIGOTE;

EID: 34547620907     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.00022-07     Document Type: Article

References (23)

1. Abe, M., J. G. Harpel, C. N. Metz, I. Nunes, D. J. Loskutoff, and D. B. Rifkin. 1994. An assay for transforming growth factor-beta using cells transfected with a plasminogen activator inhibitor-1 promoter-luciferase construct. Anal. Biochem. 216:276-284.
2. Araujo-Jorge, T. C., M. C. Waghabi, A. M. Hasslocher-Moreno, S. S. Xavier, L. Higuchi Mde, M. Keramidas, S. Bailly, and J. J. Feige. 2002. Implication of transforming growth factor-pi in Chagas disease myocardiopathy. J. Infect. Dis. 186:1823-1828.
3. Bonniaud, P., P. J. Margetts, M. Kolb, J. A. Schroeder, A. M. Kapoun, D. Damm, A. Murphy, S. Chakravarty, S. Dugar, L. Higgins, A. A. Protter, and J. Gauldie. 2005. Progressive transforming growth factor β1-induced lung fibrosis is blocked by an orally active ALK5 kinase inhibitor. Am. J. Respir. Crit. Care Med. 171:889-898.
4. Callahan, J. F., J. L. Burgess, J. A. Fornwald, L. M. Gaster, J. D. Harling, F. P. Harrington, J. Heer, C. Kwon, R. Lehr, A. Mathur, B. A. Olson, J. Weinstock, and N. J. Laping. 2002. Identification of novel inhibitors of the transforming growth factor β1 (TGF-β1) type 1 receptor (ALK5). J. Med. Chem. 45:999-1001.
5. Cavallesco, R., and M. E. Pereira. 1988. Antibody to Trypanosoma cruzi neuraminidase enhances infection in vitro and identifies a subpopulation of trypomastigotes. J. Immunol. 140:617-625.
6. de Gouville, A. C., V. Boullay, G. Krysa, J. Pilot, J. M. Brusq, F. Loriolle, J. M. Gauthier, S. A. Papworth, A. Laroze, F. Gellibert, and S. Huet. 2005. Inhibition of TGF-β signaling by an ALK5 inhibitor protects rats from dimethylnitrosamine-induced liver fibrosis. Br. J. Pharmacol. 145:166-177.
7. de Souza, E. M., T. C. Araujo-Jorge, C. Bailly, A. Lansiaux, M. M. Batista, G. M. Oliveira, and M. N. Soeiro. 2003. Host and parasite apoptosis following Trypanosoma cruzi infection in in vitro and in vivo models. Cell Tissue Res. 314:223-235.
8. Gazzinelli, R. T., I. P. Oswald, S. Hieny, S. L. James, and A. Sher. 1992. The microbicidal activity of interferon-gamma-treated macrophages against Trypanosoma cruzi involves an L-arginine- dependent, nitrogen oxide-mediated mechanism inhibitable by interleukin-10 and transforming growth factor-beta. Eur. J. Immunol. 22:2501-2506.
9. Hall, B. S., and M. A. Pereira. 2000. Dual role for transforming growth factor β-dependent signaling in Trypanosoma cruzi infection of mammalian cells. Infect. Immun. 68:2077-2081.
10. Ho, D. M., J. Chan, P. Bayliss, and M. Whitman. 2006. Inhibitor-resistant type I receptors reveal specific requirements for TGF-β signaling in vivo. Dev. Biol. 295:730-742.
11. Inman, G. J., F. J. Nicolas, J. F. Callahan, J. D. Harling, L. M. Gaster, A. D. Reith, N. J. Laping, and C. S. Hill. 2002. SB-431542 is a potent and specific inhibitor of transforming growth factor-beta superfamily type I activin receptor-like kinase (ALK) receptors ALK4, ALK5, and ALK7. Mol. Pharmacol. 62:65-74.
12. Khan, R., and R. Sheppard. 2006. Fibrosis in heart disease: understanding the role of transforming growth factor-beta in cardiomyopathy, valvular disease and arrhythmia. Immunology 118:10-24.
13. Laping, N. J., E. Grygielko, A. Mathur, S. Butter, J. Bomberger, C. Tweed, W. Martin, J. Fornwald, R. Lehr, J. Harling, L. Gaster, J. F. Callahan, and B. A. Olson. 2002. Inhibition of transforming growth factor (TGF)-β1-induced extracellular matrix with a novel inhibitor of the TGF-β type I receptor kinase activity: SB-431542. Mol. Pharmacol. 62:58-64.
14. Lawrence, D. A. 2001. Latent-TGF-β: an overview. Mol. Cell. Biochem. 219:163-170.
15. Massague, J., and R. R. Gomis. 2006. The logic of TGFβ signaling. FEBS Lett. 580:2811-2820.
16. Meirelles, M. N., T. C. de Araujo-Jorge, C. F. Miranda, W. de Souza, and H. S. Barbosa. 1986. Interaction of Trypanosoma cruzi with heart muscle cells: ultrastructural and cytochemical analysis of endocytic vacuole formation and effect upon myogenesis in vitro. Eur. J. Cell Biol. 41:198-206.
17. Ming, M., M. E. Ewen, and M. E. Pereira. 1995. Trypanosome invasion of mammalian cells requires activation of the TGF β signaling pathway. Cell 82:287-296.
18. Moncayo, A. 2003. Chagas disease: current epidemiological trends after the interruption of vectorial and transfusional transmission in the Southern Cone countries. Mem. Inst. Oswaldo Cruz 98:577-591.
19. Samudio, M., S. Montenegro-James, E. Kasamatsu, M. Cabral, A. Schinini, A. Rojas De Arias, and M. A. James. 1999. Local and systemic cytokine expression during experimental chronic Trypanosoma cruzi infection in a Cebus monkey model. Parasite Immunol. 21:451-460.
20. Silva, J. S., D. R. Twardzik, and S. G. Reed. 1991. Regulation of Trypanosoma cruzi infections in vitro and in vivo by transforming growth factor beta (TGF-β). J. Exp. Med. 174:539-545.
21. 2-macroglobulin. Infect. Immun. 70:5115-5123.
22. Waghabi, M. C., M. Keramidas, S. Bailly, W. Degrave, L. Mendonca-Lima, N. Soeiro Mde, N. Meirelles Mde, S. Paciornik, T. C. Araujo-Jorge, and J. J. Feige. 2005. Uptake of host cell transforming growth factor-beta by Trypanosoma cruzi amastigotes in cardiomyocytes: potential role in parasite cycle completion. Am. J. Pathol. 167:993-1003.
23. Waghabi, M. C., M. Keramidas, J. J. Feige, T. C. Araujo-Jorge, and S. Bailly. 2005. Activation of transforming growth factor beta by Trypanosoma cruzi. Cell. Microbiol. 7:511-517.